BIO Letter to Congressional Leadership on the Give Kids a Chance Act & Reauthorization of the Pediatric Priority Review Voucher Program (PPRV)
March 7, 2025
One thing that we can all agree on is the need to give our children a fighting chance so they can lead long and productive lives. That is why it is critical to pass the bipartisan Give Kids a Chance Act and ensure the Pediatric Priority Review Voucher Program (PPRV) is reauthorized. This program will provide greater certainty to small biotech companies, but more importantly, hope to children and families living with rare diseases.
Download Full Comments Below
2025-03-07 Letter from John F. Crowley to House and Senate Leadership
Chairman Cassidy, Ranking Member Sanders, and distinguished Members of the Committee:Thank you for the opportunity to appear before you today on behalf of the Biotechnology Innovation Organization (BIO), which represents more than 1,000…
Phyllis Arthur, EVP, Health Policy and Programs, “Vaccines are one of the most important and effective innovations for the defense of public health. They have saved millions of lives and drastically reduced or eliminated deadly and debilitating…
Re: Docket No. CDC-2025-0454; Advisory Committee on Immunization Practices (ACIP)The Biotechnology Innovation Organization (BIO) is appreciative of the opportunity to provide comments to the Advisory Committee on Immunization Practices (ACIP) in…
One thing that we can all agree on is the need to give our children a fighting chance so they can lead long and productive lives. That is why it is critical to pass the bipartisan Give Kids a Chance Act and ensure the Pediatric Priority Review Voucher Program (PPRV) is reauthorized. This program will provide greater certainty to small biotech companies, but more importantly, hope to children and families living with rare diseases.